Gender differences in chronic obstructive pulmonary diseases: A narrative review

Panminerva Medica

Volumn 60, Issue 4, 2018, Pages 192-199

  Nicolini, Antonello ^c   Barbagelata, Elena ^a   Tagliabue, Elena ^b   Colombo, Daniela ^b   Monacelli, Fiammetta ^b   Braido, Fulvio ^b  

^a General Hospital   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Hospital of Sestri Levante   (Italy)

Author keywords

Chronic obstructive pulmonary disease; Lung diseases; Patient centered care; Sex

Indexed keywords

OXYGEN;

ADULT; AGED; AGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPLICATION; FEMALE; HUMAN; HYPERTENSION; INFLAMMATORY BOWEL DISEASE; LUNG; MALE; MENTAL DISEASE; MIDDLE AGED; OSTEOPOROSIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; QUALITY OF LIFE; REFLUX ESOPHAGITIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX FACTOR; SMOKING; SPIROMETRY;

ADULT; AGED; AGING; ARTHRITIS, RHEUMATOID; COMORBIDITY; ESOPHAGITIS, PEPTIC; FEMALE; HUMANS; HYPERTENSION; INFLAMMATORY BOWEL DISEASES; LUNG; MALE; MENTAL DISORDERS; MIDDLE AGED; OSTEOPOROSIS; OXIDATIVE STRESS; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SEX FACTORS; SMOKING; SPIROMETRY;

EID: 85058889743     PISSN: 00310808     EISSN: 18271898     Source Type: Journal    
DOI: 10.23736/S0031-0808.18.03463-8     Document Type: Review

References (78)

1. Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep 2013;61:1–117.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—united States, 1971-2000. MMWR Surveill Summ 2002;51:1–16.
3. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med 2004;10:98–103.
4. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370:765–73.
5. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001;119:1691–5.
6. Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis 2014;9:1145–54.
7. Ohar J, Fromer L, Donohue JF. Reconsidering sex-based stereotypes of COPD. Prim Care Respir J 2011;20:370–8.
8. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al.; BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741–50.
9. Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res 2013;162:208–18.
10. Camp PG, Goring SM. Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4:686–91.
11. Mackay J, Amos A. Women and tobacco. Respirology 2003;8:123–30.
12. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al.; Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182:693–718.
13. Vijayan VK. Chronic obstructive pulmonary disease. Indian J Med Res 2013;137:251–69.
14. Zhou Y, Chen R. Risk factors and intervention for chronic obstructive pulmonary disease in China. Respirology 2013;18(Suppl 3):4–9.
15. Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ 2000;78:1078–92.
16. Dransfield MT, Davis JJ, Gerald LB, Bailey WC. Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir Med 2006;100:1110–6.
17. Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Camp-bell EJ, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:2152–8.
18. Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, et al.; COPDGene Investigators. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and Afri-can American race in the COPDGene Study. Am J Respir Crit Care Med 2011;184:414–20.
19. Jordan RE, Miller MR, Lam KB, Cheng KK, Marsh J, Adab P; Analysis of the Health Survey for England. Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Thorax 2012;67:600–5.
20. Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax 2010;65:480–5.
21. Tam A, Churg A, Wright JL, Zhou S, Kirby M, Coxson HO, et al. Sex differences in airway remodeling in a mouse model of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2016;193:825–34.
22. Van Winkle LS, Gunderson AD, Shimizu JA, Baker GL, Brown CD. Gender differences in naphthalene metabolism and naphthalene-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2002;282:L1122–34.
23. Kamil F, Pinzon I, Foreman MG. Sex and race factors in early-onset COPD. Curr Opin Pulm Med 2013;19:140–4.
24. Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N, et al. Vulnerability of patients with chronic obstructive pulmonary disease according to gender in China. Int J Chron Obstruct Pulmon Dis 2012;7:825–32.
25. Torres JP, Casanova C, Pinto-Plata V, Varo N, Restituto P, Cordoba-Lanus E, et al. Sex differences in plasma biomarker levels in a cohort of COPD Patients: A Pilot Study. PLoS One 2011;6:e1602.
26. Fleisher B, Kulovich MV, Hallman M, Gluck L. Lung profile: sex differences in normal pregnancy. Obstet Gynecol 1985;66:327–30.
27. Doershuk CF, Fisher BJ, Matthews LW. Specific airway resistance from the perinatal period into adulthood. Alterations in childhood pulmonary disease. Am Rev Respir Dis 1974;109:452–7.
28. Perelman RH, Palta M, Kirby R, Farrell PM. Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics 1986;78:238–44.
29. Thurlbeck WM. Postnatal human lung growth. Thorax 1982;37:564–71.
30. Hoffstein V. Relationship between lung volume, maximal expiratory flow, forced expiratory volume in one second, and tracheal area in normal men and women. Am Rev Respir Dis 1986;134:956–61.
31. Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 2007;293:L272–8.
32. Massaro GD, Mortola JP, Massaro D. Sexual dimorphism in the architecture of the lung’s gas-exchange region. Proc Natl Acad Sci USA 1995;92:1105–7.
33. Massaro D, Massaro GD. Estrogen receptor regulation of pulmonary alveolar dimensions: alveolar sexual dimorphism in mice. Am J Physiol Lung Cell Mol Physiol 2006;290:L866–70.
34. Lowery EM, Brubaker AL, Kuhlmann E, Kovacs EJ. The aging lung. Clin Interv Aging 2013;8:1489–96.
35. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009;30:325–33.
36. Olivieri F, Lazzarini R, Recchioni R, Marcheselli F, Rippo MR, Di Nuzzo S, et al. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr) 2013;35:1157–72.
37. Fon GT, Pitt MJ, Thies AC Jr. Thoracic kyphosis: range in normal subjects. AJR Am J Roentgenol 1980;134:979–83.
38. Mobasheri A, Mendes AF. Physiology and pathophysiology of mus-culoskeletal aging: current research trends and future priorities. Front Physiol 2013;4:73.
39. Desler C, Hansen TL, Frederiksen JB, Marcker ML, Singh KK, Juel Rasmussen L. Is there a link between mitochondrial reserve respiratory capacity and aging? J Aging Res 2012;2012:192503.
40. Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985) 2000;89:81–8.
41. Kokturk N, Kilic H, Baha A, Lee SD, Jones PW. Sex Difference in Chronic Obstructive Lung Disease. Does it Matter? A Concise Review. COPD 2016;13:799–806.
42. Miravitlles M, de la Roza C, Naberan K, Lamban M, Gobartt E, Mar-tín A, et al. [Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care]. Arch Bronconeumol 2006;42:3–8. Spanish.
43. Dales RE, Mehdizadeh A, Aaron SD, Vandemheen KL, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J 2006;28:319–22.
44. Ancochea J, Miravitlles M, García-Río F, Muñoz L, Sánchez G, So-bradillo V, et al. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol 2013;49:223–9.
45. Ben-Zaken Cohen S, Paré PD, Man SF, Sin DD. The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med 2007;176:113–20.
46. Cydulka RK, Rowe BH, Clark S, Emerman CL, Rimm AR, Ca-margo CA Jr. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med 2005;12:1173–9.
47. Martinez CH, Raparla S, Plauschinat CA, Giardino ND, Rogers B, Beresford J, et al. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health (Larchmt) 2012;21:1267–74.
48. Centers for Disease Control and Prevention. National Center for Health Statistics: National Health Interview Survey raw data; 2011 [Internet]. Available from: www.cdc.gov/nchs/nhis/nhis_2011_data_release. htm [cited 2018, Jul 2].
49. Watson L, Vonk JM, Löfdahl CG, Pride NB, Pauwels RA, Laitinen LA, et al.; European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med 2006;100:746–53.
50. Celli B, Vestbo J, Jenkins CR, Jones PW, Ferguson GT, Calverley PM, et al.; Investigators of the TORCH Study. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med 2011;183:317–22.
51. Naberan K, Azpeitia A, Cantoni J, Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med 2012;106:367–73.
52. Gonzalez AV, Suissa S, Ernst P. Gender differences in survival following hospitalisation for COPD. Thorax 2011;66:38–42.
53. de Torres JP, Casanova C, de Garcini AM, Jaime AA, Celli BR. COPD heterogeneity: gender differences in the multidimensional BODE index. Int J Chron Obstruct Pulmon Dis 2007;2:151–5.
54. Martinez FJ, Curtis JL, Sciurba F, Mumford J, Giardino ND, Wein-mann G, et al.; National Emphysema Treatment Trial Research Group. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007;176:243–52.
55. Hardin M, Foreman M, Dransfield MT, Hansel N, Han MK, Cho MH, et al.; COPDGene Investigators. Sex-specific features of emphysema among current and former smokers with COPD. Eur Respir J 2016;47:104–12.
56. Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med 2007;176:1179–84.
57. Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999;54:1119–38.
58. Verhage TL, Heijdra Y, Molema J, Vercoulen J, Dekhuijzen R. Associations of muscle depletion with health status. Another gender difference in COPD? Clin Nutr 2011;30:332–8.
59. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, et al.; ECLIPSE investigators. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008;31:869–73.
60. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122.
61. Almagro P, López García F, Cabrera FJ, Montero L, Morchón D, Díez J, et al.; Grupo Epoc De La Sociedad Española De Medicina Interna. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med 2010;104:253–9.
62. Ekström MP, Jogréus C, Ström KE. Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS One 2012;7:e35806.
63. Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006;100:1767–74.
64. Divo MJ, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta JJ, et al.; BODE Collaborative Group. COPD comorbidities network. Eur Respir J 2015;46:640–50.
65. Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003;163:1180–6.
66. Kilic H, Kokturk N, Sari G, Cakır M. Do females behave differently in COPD exacerbation? Int J Chron Obstruct Pulmon Dis 2015;10:823–30.
67. Bjornson W, Rand C, Connett JE, Lindgren P, Nides M, Pope F, et al. Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health 1995;85:223–30.
68. Henoch I, Strang S, Löfdahl CG, Ekberg-Jansson A. Management of COPD, equal treatment across age, gender, and social situation? A register study. Int J Chron Obstruct Pulmon Dis 2016;11:2681–90.
69. Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, et al.; Associazione Italiana Pneumologi Ospedalieri Educational Group. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med 2006;19:127–36.
70. Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P; TRISTAN Study Group. Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. Respir Med 2004;98:1045–50.
71. O’Donnell DE, Flüge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004;23:832–40.
72. Schermer TR, Hendriks AJ, Chavannes NH, Dekhuijzen PN, Wouters EF, van den Hoogen H, et al. Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice. Prim Care Respir J 2004;13:48–55.
73. Tsiligianni I, Mezzi K, Fucile S, Kostikas K, Shen S, Banerji D, et al. Response to Indacaterol/Glycopyrronium (IND/GLY) by Sex in Patients with COPD: A Pooled Analysis from the IGNITE Program. COPD 2017;14:375–81.
74. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J 2001;31:448–54.
75. Machado MC, Krishnan JA, Buist SA, Bilderback AL, Fazolo GP, Santarosa MG, et al. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:524–9.
76. Foy CG, Rejeski WJ, Berry MJ, Zaccaro D, Woodard CM. Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest 2001;119:70–6.
77. Nguyen LP, Beck E, Cayetano K, Li CS, Hardin K. Differential pulmonary rehabilitation outcomes in patients with and without COPD: role of gender. J Cardiopulm Rehabil Prev 2017;37:350–5.
78. Laurin C, Lavoie KL, Bacon SL, Dupuis G, Lacoste G, Cartier A, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007;132:148–55.